Efficacy and safety of primary letermovir prophylaxis for cytomegalovirus infection in paediatric patients undergoing allogeneic transplantation: a single-centre, retrospective, real-world analysis. (PubMed, Clin Hematol Int) - Mar 17, 2025 - "LET is effective and safe in preventing csCMVi among Chinese children undergoing allo-HSCT. Compared to UCB recipients, children undergoing HID transplantation for the Beijing protocol develop less scCMVi up to 180 days post-HSCT."
Journal • Real-world evidence • Retrospective data • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Hematological Disorders • Hematological Malignancies • Immunology • Infectious Disease • Oncology • Pediatrics • Transplantation
|
|
Aoli Zhang; Chaoqian Jiang; Fang Liu; Lipeng Liu; Wenyu Yang; Xia Chen; Xiaofan Zhu; Xiaojuan Chen; Xiaoyan Zhang; Xin Wang; Yang Wan; Yao Zou; Ye Guo; Yuanyuan Ren; Yue Shang
|